| 66658-501-01 |
66658-501 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20190517 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
10 mg/2mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-501-01) / 2 mL in 1 VIAL, SINGLE-USE |
| 66658-523-01 |
66658-523 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20230607 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
100 mg/4mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-523-01) / 4 mL in 1 VIAL, SINGLE-USE |
| 66658-522-01 |
66658-522 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20230607 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
50 mg/2mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-522-01) / 2 mL in 1 VIAL, SINGLE-USE |
| 66658-505-01 |
66658-505 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20190517 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
50 mg/10mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-505-01) / 10 mL in 1 VIAL, SINGLE-USE |
| 66658-524-01 |
66658-524 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20230607 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
250 mg/10mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-524-01) / 10 mL in 1 VIAL, SINGLE-USE |
| 66658-510-01 |
66658-510 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20200626 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
100 mg/20mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-510-01) / 20 mL in 1 VIAL, SINGLE-USE |
| 66658-525-01 |
66658-525 |
HUMAN PRESCRIPTION DRUG |
GAMIFANT |
emapalumab-lzsg |
INJECTION |
INTRAVENOUS |
20230607 |
N/A |
BLA |
BLA761107 |
Swedish Orphan Biovitrum AB (publ) |
EMAPALUMAB |
500 mg/20mL |
1 VIAL, SINGLE-USE in 1 CARTON (66658-525-01) / 20 mL in 1 VIAL, SINGLE-USE |